Ki-Hun Kim1, Jin Oh Na1, Gi-Byoung Nam2, Eun-Sun Jin1, HyungOh Choi1, Sung-Hwan Kim1, Kee-Joon Choi1, You-Ho Kim1. 1. Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Poongnap-dong 388-1, Songpa-gu, Seoul, 138-736, Korea. 2. Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Poongnap-dong 388-1, Songpa-gu, Seoul, 138-736, Korea. gbnam@amc.seoul.kr.
Abstract
BACKGROUND: Catheter ablation (CA) is reported to improve left ventricular (LV) function in patients with atrial fibrillation (AF). This study compared the effects of CA and antiarrhythmic drug treatment (AT) on LV remodeling and other echocardiography parameters in AF. METHODS: We performed a non-randomized prospective study involving 72 drug-resistant AF patients who were treated with either CA (n = 42) or who declined CA and continued on AT (n = 30). Baseline and follow-up (mean 20.7 ± 7.5 months) echocardiography was performed in all patients. The maintenance of sinus rhythm was determined based on clinical interview, electrocardiography, and 24-h Holter and event recording. RESULTS: There were no significant differences between the two groups in regard to demographic features, blood pressure, and medication. CA was superior to AT with respect to sinus rhythm maintenance, LV ejection fraction, left atrium (LA) diameter, and LA volume index. In addition, CA resulted in decreases in the LV mass [from 190.5 ± 36.1 to 179.3 ± 32.4 g (p = 0.02)] and the LV mass index [from 104.2 ± 20.5 to 98.2 ± 18.3 g/m(2) (p = 0.03)]. No parameter improved in AT patients. These improved echocardiographic parameters were observed in both groups with maintained sinus rhythm. CONCLUSION: Reverse LV remodeling after CA may include a reduction in the LV mass index, which appears to be associated with sinus rhythm maintenance.
BACKGROUND: Catheter ablation (CA) is reported to improve left ventricular (LV) function in patients with atrial fibrillation (AF). This study compared the effects of CA and antiarrhythmic drug treatment (AT) on LV remodeling and other echocardiography parameters in AF. METHODS: We performed a non-randomized prospective study involving 72 drug-resistant AFpatients who were treated with either CA (n = 42) or who declined CA and continued on AT (n = 30). Baseline and follow-up (mean 20.7 ± 7.5 months) echocardiography was performed in all patients. The maintenance of sinus rhythm was determined based on clinical interview, electrocardiography, and 24-h Holter and event recording. RESULTS: There were no significant differences between the two groups in regard to demographic features, blood pressure, and medication. CA was superior to AT with respect to sinus rhythm maintenance, LV ejection fraction, left atrium (LA) diameter, and LA volume index. In addition, CA resulted in decreases in the LV mass [from 190.5 ± 36.1 to 179.3 ± 32.4 g (p = 0.02)] and the LV mass index [from 104.2 ± 20.5 to 98.2 ± 18.3 g/m(2) (p = 0.03)]. No parameter improved in AT patients. These improved echocardiographic parameters were observed in both groups with maintained sinus rhythm. CONCLUSION: Reverse LV remodeling after CA may include a reduction in the LV mass index, which appears to be associated with sinus rhythm maintenance.
Authors: Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart Journal: J Am Soc Echocardiogr Date: 2005-12 Impact factor: 5.251
Authors: Philip J Gentlesk; William H Sauer; Edward P Gerstenfeld; David Lin; Sanjay Dixit; Erica Zado; David Callans; Francis E Marchlinski Journal: J Cardiovasc Electrophysiol Date: 2006-11-01
Authors: Denis Roy; Mario Talajic; Marc Dubuc; Bernard Thibault; Peter Guerra; Laurent Macle; Paul Khairy Journal: Curr Opin Cardiol Date: 2009-01 Impact factor: 2.161
Authors: Patricia Reant; Stephane Lafitte; Hanane Bougteb; Frederic Sacher; Aude Mignot; Herve Douard; Pierre Blanc; Meleze Hocini; Jacques Clementy; Michel Haissaguerre; Raymond Roudaut; Pierre Jais Journal: Am J Cardiol Date: 2008-11-07 Impact factor: 2.778
Authors: Giovanni B Forleo; Massimo Mantica; Lucia De Luca; Roberto Leo; Luca Santini; Stefania Panigada; Valerio De Sanctis; Augusto Pappalardo; Francesco Laurenzi; Andrea Avella; Michela Casella; Antonio Dello Russo; Francesco Romeo; Gemma Pelargonio; Claudio Tondo Journal: J Cardiovasc Electrophysiol Date: 2008-09-03